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ABSTRACT
More women are going through the menopausal transition today than at any time 
in the history of our civilization. The number of women greater than 50 years of age has 
increased by 27% between 1990 and 2000, and is expected to increase by another 9% by 
2020. Women who are transitioning through menopause often experience a variety of 
symptoms, including hot flashes, night sweats, insomnia, irritability, memory loss, 
decreased libido, and depression. Symptoms occurring during the menopausal transition 
may also be confused with changes associated with aging, including increased abdominal 
obesity, insulin resistance, and the metabolic syndrome; for example, fatigue, brain 
fogginess, feeling agitated and moody, and depression
While studies have explored the relationship between carbohydrate, fat, and fiber 
content on weight and fat loss, and diabetic risk, and other chronic diseases, only one 
study was found that specifically linked dietary intake with a reduction in menopausal 
symptoms. The purpose of this study was to explore and compare dietary intake, 
specifically carbohydrate and fiber, and its effect on menopausal symptoms. Menopausal 
status and its effect on menopausal symptoms were also examined.
The conceptual framework used for this study was physiological adaptation. The 
population of the study consisted of Caucasian women ranging in ages from 42-65. The 
convenience sample was drawn mostly from university staff in a Midwestern city, and 
most of the women was married, perimenopausai, not on hormonal replacement therapy,
x
and had a total of two pregnancies. The study was descriptive in design, and employed 
three self-reported tools to acquire the information needed for the study. The 
investigators secured IRB approval from the university prior to soliciting participants, 
and consent forms were signed prior to filling out the questionnaires. The data was 
analyzed by using SPSS, and Cronbach’s co-efficiency test, t-test, Chi-Square, Pearsorf s 
r correlation, and Hierarchical Regression Models statistical tests.
The results showed no statistical significant relationship between dietary intake of 
carbohydrate and fiber and menopause symptoms, however there was some clinical 
significance found when looking at the effect size. Carbohydrates and grains did have 
practical significance showing a small effect over and above all of the other predictors on 
menopausal symptom s. This effect was independent of sample size, and the findings may 
show natural alternatives to relieving menopausal symptoms and deserve further study. 
These findings have implications for aging women and their primary health care 
providers, and provide a basis for further research and development of nursing theory 
related to dietary intake and menopausal symptoms.
xi
CHAPTER 1
REVIEW OF LITERATURE 
Introduction
There are more women going through the menopausal transition today than at any 
time in the history of our civilization. According to the North American Menopause 
Society, “in year 2000, almost 4300 U.S. women reached menopause per day, totaling 
close to 1.6 million women in that year. The number of women greater than 50 years of 
age has increased by 27% between 1990 and 2000, and is expected to increase by another 
9% by 2020” (North American Menopausal Society, 2004). Large numbers of women are 
reaching the menopausal transition which has implications for the women and their 
health, as well as their adjustment to this new phase of their lives. Due to the large 
number of women reaching this status, and the recent HRT study findings, women are 
looking for natural alternatives to relieve their menopausal symptoms. Dietary intake is 
one natural alternative that women may use to affect changes to alleviate these 
symptoms, and very little research has been conducted on dietary intake’s effects on 
menopause symptoms.
Purpose of Study
The purpose of this study was to explore the relationship between dietary intake 
of carbohydrates and fiber and menopausal symptoms. The following research questions 
were investigated:
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1. What is the relationship between dietary intake of carbohydrates and the 
severity of menopausal symptoms in perimenopausal and postmenopausal 
women?
2. What is the relationship between dietary intake of fiber and the severity of 
menopausal symptoms in perimenopausal and postmenopausal women?
Symptoms Occurring in the Menopausal Transition 
The menopausal transition is typically accompanied by a variety of symptoms -  
symptoms that may add additional stress to a woman’s physical and psychological status. 
Symptoms may range from hot flashes, irritability, night sweats, and memory loss to 
insomnia, sexual changes, and depression (Gold et al,, 2004). The severity of symptoms 
varies according to body mass, passive cigarette smoke exposure, hormonal levels, and 
by race and ethnicity (Gold et al., 2004). Vasomotor symptoms, some of the most 
common symptoms of menopause, include hot flushes, cold hands and feet, heart 
palpitations, shortness of breath, numbness and tingling, loss of feeling in the hands and 
feet, dry eyes, and headaches (Hansen, 1998). Reported by up to 75% of women, the hot 
flash is the second most frequent symptom of the perimenopausal period, and is exceeded 
only by irregular menses (North American Menopause Society, 2004). The term 
perimenopausal, in this study, will be defined as a woman nearing the menopause 
transition but still menstruating. A temperature change of up to seven degrees may occur 
causing the body to readjust its thermostat many times during the day (Hansen, 1998). 
Other somatic symptoms include vaginal dryness, decreased sexual libido, urinary 
complaints, and joint and muscular complaints (Perz, 1997).
2
tense feelings, excitability, depressed feelings, moodiness, irritability, pressure or
tightness in the head or body, crying spells, and needless worry (Perz, 1997).
Psychological symptoms are often difficult to assess as to whether they are hormone
related or there is a deficit of neurological transmitters or both. Further assessment may
need to be conducted to determine the origin of these particular symptoms.
Hormonal changes associated with perimenopause and postmenopause place a
woman at risk of experiencing the various symptoms highlighted above. Table 1
summarizes the relationship between hormones and symptoms.
Table 1. Hormonal Changes and Risk of Symptoms of Perimenopausal & 
Postmenopausal Women.
Psychological symptoms of menopause are diverse and diffuse, and often include
Menopausal Symptom Estradiol Testosterone Progesterone
Vaginal Atrophy/ Urinary 
incontinence Decreased Decreased Increased





Thin, fragile, dry skin Decreased Decreased Decreased
Adapted from Collins, J. (2001). Management of menopause type® seminar, accessed 
2-13-05, www.yourmenopausetype.com.
Quality of Life
Symptoms experienced by a woman during the menopausal transition may also 
have a bearing on how the woman perceives her quality of life. Garanszegi et al. (1998)
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found that “women equated menopause to the experience of menopausal symptoms 
(p. 171).” They postulated that it is the occ urrence of symptoms and not the cessation of 
menses that causes a woman to consider herself to be actively going through the 
menopausal transition. Depending on how severe the symptoms are perceived to be, they 
may affect a woman’s quality of life as well. Assessing the woman’s quality of life is 
important in identifying the way the woman feels about herself and how well she 
functions in normal daily affairs (Wiklund, 1998). According to Utian (2002), assessing a 
woman’s quality of life is essential to determining “the woman’s global sense of self- 
satisfaction, how she felt generally and specifically with interest in life, and ability to 
complete a day’s work, maintain satisfactory interpersonal relationships, and a general 
feeling of wellness (p. 403).” Thus, a woman’s quality of life appears to be an important 
variable to consider when assessing a woman’s experience in the perimenopausal or 
postmenopausal periods.
Menopausal Symptom Instruments
A variety of instruments have been used to measure the diversity and severity of 
menopausal symptoms, including the Blatt-Kuppcrman Index (Greene, 1976), the Greene 
Climacteric Scale (Greene, 1998), the Women’s Health Questionnaire (Hunter, 2000), the 
Menopausal Symptom List (Perz, 1997), and the Menopausal Rating Scale (Schneider, 
Heinemann, Rosemeier, Potthoff, & Behre, 2000). Now considered outdated, the Blatt- 
Kupperman Index was one of the first instruments used by physician’s to assess the 
severity of menopausal symptoms. Finding the Blatt Menopausal Index to be inadequate, 
Greene (1976) developed the Greene Climacteric Scale, the first scale of its type to be 
constructed using a factor analysis (Greene, 1998). Rather than a list of symptoms (as in
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the Blatt-Kupperman Index), Greene’s instrument grouped 21 symptoms according to 
subscales: vasomotor, somatic, anxiety, and depression. Subsequent scales were also 
constructed based on factor analysis. For example, the Women’s Health Questionnaire 
(Hunter, 2000) has 32 symptoms and consists of eight subscales, four of which are the 
same as the Greene Climacteric Scale. The Menopausal Symptom List (Perz., 1997) has 
25 symptoms and three subscales: vaso-somatic, general somatic and psychological. The 
Menopause Rating Scale (Schneider, Heinemann, Rosemeier, Potthoff, and Behre, 2000), 
constructed by German physicians, has eleven items with three independent dimensions, 
or subscales: somatic, psychological and urogenital.
Two instruments specifically evaluating a woman’s quality of life have been 
developed. The Menopause-Specific Quality of Life Questionnaire (Hilditch, et al., 1996) 
focuses on the postmenopausal period and addresses “condition-specific quality of life (p. 
162).” This tool was constructed using the importance score method which was based on 
the frequency of occurrence and degree to which the women considered the symptom to 
be annoying. It resulted in 30 items with four domains: vasomotor, physical, 
psychosocial, and sexual. It has been criticized for not adequately addressing culturally 
sensitive concerns (Bener et al., 2000). Utian, Janata, Kingsberg, Schlucnter, Hamilton 
(2002), asserted that quality of life (QOL) is more than symptoms, and is based on the 
woman’s perception of well-being. Their instrument, the Utian Quality of Life Scale, has 
23 items with four components of Quality of Life: occupational, health, emotional, and 
sexual. Refer to Tables 2 and 3 for a summary of characteristics for these instruments.
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Table 2. Subscale Structure of Menopause-Specific Scales.
Blatt- Greene Women’s Menopausal Menopause Menopause- U tian  Q O L
Kupperman Climacteric Health Symptom Rating Scale Specific QOL Scale
Index Scale Questionnaire List Questionnaire
No V asomotor Vasomotor Vasosomatic Somatovegetative Physical Occupational
subscales
Somatic Somatic General Urogenital Vasomotor
QOL
somatic Health QOL







Adapted from Schneider, HPG. (2002). The quality of life in the post-menopausal woman, Best Practice & 
Research Clinical Obstetrics and Gynaecology, 16(3): 395-409.











Blatt-Kupperman Index 11 3 Severity 0 Not
Available
Greene Climacteric Scale 21 4 Severity 8 0.83-0.87
Women’s Health 
Questionnaire
32 2 Preserit/Absent 8 0.78-0.96
Menopausal Symptom List 25 6 F requency/Severity 3 0.74-0.82
Menopause Rating Scale 11 5 Severity 3 0.60 (average)
Menopause-Specific QOL 
Questionnaire
30 7 Severity 4 0.55-0.81
Utian QOL Scale 23 5 Severity 4 Not Available
Adapted from Schneider, HPG. (2002). The quality of life in the post-menopausal woman, Best practice & research clinical 
obstetrics and gynaecology, 16(3): 395-409.
Menopause and the Metabolic Syndrome
The following sections are based on the assumption that a complex interaction 
exists between hormonal changes during the menopausal transition, the rising incidence 
of insulin resistance and ultimately the metabolic syndrome, dietary intake, and resulting 
physical, cognitive, and emotional symptoms. A review of literature did not reveal a 
direct connection between the menopausal transition and any physical or cognitive 
changes occurring as a women ages nor the mechanism involved. A review of literature 
showed that as women age, there is a rising incidence of insulin resistance and 
concurrently the metabolic syndrome. It is further conjectured that carbohydrates play an 
important role in that cascade of events. There has been a growing popularity of the 
Atkins and other low carbohydrate diets. Further, in the investigators’ experience, 
perimenopausal and postmenopausal women have reported anecdotally that they 
experience an improvement in their symptoms when they alter the type and quantity of 
carbohydrates in their diets; that is, symptoms appear to diminish when they decrease 
their intake of refined sugars, white potatoes, white rice, sweet desserts, and other foods 
that are considered high in the glycemic index. Yet an extensive review of literature has 
not revealed a direct connection between carbohydrate intake and menopausal symptoms. 
The following discussion will present a summary of literature explored.
Symptoms occurring during the menopausal transition may be confused with 
changes associated with aging, including increased abdominal obesity, insulin resistance, 
and the metabolic syndrome. Examples of these symptoms include depression, 
moodiness, and feeling agitated. Other symptoms associated with aging include bone and 
joint tenderness, urinary problems, and fatigue Along with these symptoms of aging and
8
menopause, one study by Otte (2005) addressed how women in particular are at increased 
risk for developing age-related diseases because of their increased cortisol response. This 
section will explore the relationship between aging, the metabolic syndrome, and 
menopause.
As women age, they are at increased risk for cardiovascular disease, hypertension, 
and insulin resistance and Type 2 diabetes. In addition to metabolic and hormonal 
changes associated with aging, it is noted that women and older adults are among the 
most sedentary and obese subsets of the U.S. population (Obesity Education Initiative 
Task Force, 1998). Nearly one-third of all women in the U.S. are overweight and another 
one-third are obese. The obesity rise peaks in women in their 40’s and 50’s, occurring 
concurrently with the menopausal transition. Further, being postmenopausal, obese, and 
having a sedentary lifestyle are independent risk factors for cardiovascular disease 
(CVD), including atherosclerosis and myocardial infarction (Manson et al,, 1990; Carels, 
Darby, Cacciopaglia, & Douglass, 1990). CVD is the leading cause of mortality and 
morbidity among U.S. women after the age of 50 (Carels, Darby, Cacciopaglia, & 
Douglass, 2004), and approximately 50% of the cardiovascular events in women are 
related to the metabolic syndrome (Carr, 2004).
It is becoming increasingly clear that hypertension and metabolic risk factors in 
women are inter-related and often share underlying causes. Menopause acts 
explicitly as a risk factor by reducing the direct beneficial effect of ovarian 
hormones upon cardiovascular functions and indirectly by negatively influencing 
other risk factors for coronary artery disease -- i.e. hyper-insulinaemia, blood
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cholesterol, blood pressure, coagulation etc. (Rosario, Vitale, Silvestri, & Fini,
2004, p. 20.)
Some researchers (Carr, 2004; Spencer, Godsland, Stevenson, 1997) have 
suggested that a “menopausal metabolic syndrome” exists. It is conjectured that the 
decrease in estradiol-17 beta (a corollary of the menopausal transition) is associated with 
a woman’s increased risk of postmenopausal metabolic syndrome. Evidence suggests that 
the drop in estradiol-17 beta accounts for increased total cholesterol and triglycerides; 
decreased high density lipoprotein (HDI.) and HDL sub fraction 2; increased low density 
lipoprotein (LDL), especially the small, dense sub fractions; increased lipoprotein (a); 
increased insulin resistance; decreased insulin secretion and elimination; increased 
android fat distribution (central abdominal adiposity); impaired vascular function; 
increased factor VII and fibrinogen, and reduced sex hormone binding globulin (Spencer, 
Godsland, & Stevenson, 1997; Carr, 2003). This set of changes is complex and a detailed 
discussion is not given here. However, a key element that is consistent in the literature is 
the accelerated “selective deposition of intra-abdominal fat (Tchernof, Poehlman, & 
Despres, 2000, p. 12)” during the menopausal transition. Controversy exists as to whether 
it is the decrease in estrogen that contributes to the metabolic syndrome or other factors 
that may be involved as well. What is clear is that weight gain, and particularly obesity, 
has a strong influence on the development of impaired glucose metabolism (Tufano, 
Marzo, Marricone, Caviezel, & Amrosi, 2004, Carr, 2003), and that women with higher 
visceral abdominal fat had higher insulin and triglyceride levels (Kim et al., 2004) It is 
also widely accepted that obesity and hypertension are significantly related (Wilson, 
D’Agostino, Sullivan, Parise, & Kennel, 2002).
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Dietary Intake and Chronic Disease
Several studies examine various examples of dietary combinations and their 
impact on developing insulin resistance, weight loss in obese patients, and better control 
in diabetic patients aimed at decreasing risk for CVD. However, no one method of dietary 
combinations has been found to be conclusive. Studies have focused on the carbohydrate 
and fat content of diets. Hollenbeck and Coulston (1991) indicated that “the major 
emphasis in recent years has been on the reduction of total fat and saturated fat and 
replacement with complex carbohydrate (p. 774).” Simkin-Silverman and Wing (2.000). 
suggested that “low fat diets may aggravate the effect of insulin resistance on blood 
lipids, and suggest a diet low in saturated fat (<10% of total calories) and more moderate 
in total fat (40% of calories) for those who are insulin resistant (p. 53).” In a comparison 
of two high-carbohydrate (40% and 60%),. low-fat diets, Coulston, Liu, and Reaven 
(1983) found no differences in fasting plasma glucose, insulin or cholesterol levels. 
However, they reported that fasting plasma triglyceride levels were significantly elevated 
and the high density lipoproteins (HDL) levels were significantly decreased in the 
individuals on the 60% carbohydrate diet. In a similar study, Tavani et al. (2003) found 
that individuals who consumed a high-carbohydrate diet had an increased the 
concentration of very low density lipoproteins and triglycerides and a decrease of the 
high density lipoproteins. In contrast, results of low-carbohydrate (<20 grams/day or 
<10% of daily caloric intake) diets consistent with the popular Atkins approach higher fat 
and protein intakes were compared to those of low-fat (30% fat with 55% carbohydrate 
and 15% protein) diets. Brehm et al. (2002) found that obese women in the low- 
carbohydrate diet group lost more weight, and more body fat and lean body mass than
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women in the low fat diet group. Lipid profiles improved for both groups, with 
significant decreases in total cholesterol, LDL cholesterol, and triglycerides at three 
months and significant increases in HDL cholesterol at six months. Glucose, insulin and 
plasma leptin levels significantly decreased during the study. Similarly, Yancy et al. 
(2004) in a study of obese, hyperlipidemic individuals (sample consisted of 
approximately 70% women) found greater weight loss, reduced serum triglyceride and 
increased HDL cholesterol levels in the low-carbohydrate diet group as compared to the 
low-fat diet group. The study conducted by Salmeron et al. (1997) found that a diet with a 
high glycemic load and a low fiber intake (primarily cereal fiber) showed an increased 
risk of Type 2 diabetes in men. Various types of dietary changes showed improvements 
in weight losses and blood serum levels, but no long term studies have been done with 
any of these diets. The National Center for Complementary and Alternative Medicine has 
recently funded a long term study (April 2003 -  May 2007) that compares the impact of a 
low-carbohydrate diet with a conventional high-carbohydrate, low-fat diet on weight, 
body composition, metabolic and organ function, and exercise tolerance (NCCAM,
2005). Table 4 summarizes some of the results of the above studies.
Other studies focused on the fiber content of foods and its impact on metabolism 
and weight. Liu et al. (2003) did a twelve years study and compared the weight change of 
women based on their intake of grains. Women who ate more whole grains had a 
decrease in weight while those who ate more refined grains (white bread, pasta, rice) 
experienced an increase in their weight. Kilocalories were kept relatively constant 
between the two groups despite the varying diets. Various studies have demonstrated 
“inverse relationships between whole-grain intake and ischemic stroke and coronary
12
Table 4. Comparisons of Outcomes by Diet and Type.
Author / Authors of Study Diet Type Studied Outcomes of Study
Coulston, Liu, & Reaven 
(1983)
Compared 40% and 60% 
High Carbohydrate Diets 
and Low fat Diets
Similar fasting glucose, 
insulin, and cholesterol 
levels, decreased HDL, 
increased triglicerides
Tavani et al. (2003) High Carbohydrate Increased LDL and VLDL 
Decreased HDL
Brehm (2002) Compared:
Low Carbohydrate (<10% 
daily) to Low Fat (55% 
carb/15% fat)
Low carbohydrate group: 
Increased weight loss 
Increased body fat loss
Yancy et al. (2004) Low Carbohydrate Increased weight loss 
Decreased triglicerides 
Increased HDL
artery disease risk and deaths” (Fung et al., 2002, p. 539). Further research demonstrated 
that diets low in fiber were associated with significant increases in colorectal cancer 
(Higgenbotham et al (2004). Salmeron et al., (1997) and Fung et al., (2001) reported a 
strong relationship between total intake of dietary fiber and a decreased risk of Type 2 
diabetes. While these studies do not appear to have a direct impact on menopausal 
symptoms, they speak to the interrelationship between dietary intake and resulting 
physiologic adaptation of the body. In their study, Fung el al. (2002), also found that 
participants (in this case, men) “with higher whole-grain intakes tended to be leaner and 
more physically active, to consume less fat, and be less likely to smoke...” (p. 537).
Thus, the variable of dietary fiber may be a substitute for other characteristics that are 
interrelated with physical manifestations. Another example of the complexities of
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studying dietary fiber is its relationship to phytoestrogens. Intake of phytoestrogens has 
been associated with a decrease in vasomotor symptoms associated with menopause 
(Rakel, 2003). One of the components of phytoestrogens is lignan which is found in 
flaxseed and in most cereal grains and vegetables. Thus, it could be the phytoestrogens, 
and not the fiber that is related to a decrease in symptoms. However, women in the study 
were less likely to consume measurable quantities of phytoestrogens; thus measurements 
of fiber may serve as a proxy for other nutrients. Gold et al. (2004), assessed diet and 
menopausal vasomotor symptoms. Though the relationship between a high fiber diet and 
reduced vasomotor symptoms was not statistically significant, fewer vasomotor 
symptoms were noted among the Asian women in the study. Lupton, (2002) from the 
National Academies of Sciences announced the RDI (recommended daily intake) for 
fiber intake which was derived from assessing comprehensive literature on dietary 
studies. The official guidelines recommend 25 grams of total fiber for men and women 
per day, and that the intake comes from whole grain foods rather than food supplements, 
(United States Department of Agriculture, 2005). The RDI for women over 50 years is 21 
grams of total fiber per day. The National Cancer Institute recommends 25 grams of 
dietary fiber with an upper limit of 35 grams per day with a mix of soluble and insoluble 
fiber. Therefore, a diet high in fiber may not show a direct correlation with a reduction of 
menopausal symptoms in this study, however, the numerous studies listed above indicate 
that a high fiber diet may reduce risk for or prevent chronic disease.
Dietary Intake and Menopause
While a number of studies have explored the impact of varying levels of dietary 
carbohydrates and fat on weight loss, metabolism, and serum profiles, little attention has
14
been given to dietary intake for the woman experiencing the menopausal transition. The 
North American Menopause Society (2004) recommends a diet “high in grain products, 
vegetables, and fruits as well as low in saturated fats and cholesterol (p. 89).” The 
current recommendations include at least five fruit and vegetable servings and eight 
glasses o f fluid daily, with decreased use of sugar, salt and alcohol. Because of the 
propensity for weight gain during the perimenopausal period, and particularly central 
adiposity, women are encouraged to decrease fats in their diets and to ensure adequate 
physical activity to balance energy intake. Stokes (2003) recommends including a variety 
of fruits and vegetables to relieve menopausal symptoms and promote health. Collins 
(2000) suggested that certain fruits and vegetables contain phytoestrogens which are 
“plant substances that have estrogen-like activities, and may be significant in easing the 
symptoms of menopause (p. 35).” Only one study was found that specifically linked 
dietary intake with a reduction in menopausal symptoms. Park et al. (2003) found that 
perimenopausal and postmenopausal Korean women who ate more fish, soy, fruits, and 
vegetables and less red meat, salt, sugar, processed foods, and coffee had fewer 
vasomotor symptoms, including hot flushes and night sweats.
There may also be a connection between perimenopausal and premenstrual 
symptoms. Since hormonal changes during the perimenopausal period often mirror those 
experienced premenstrually (a drop in progesterone and estrogen levels), dietary changes 
resulting in improved premenstrual symptoms may affect perimenopausal women in a 
similar manner. While the impact of dietary intake is inconclusive, studies (Johnson et 
al., 1995; Johnson, 1998; Christensen, 1997) have suggested a relationship between 
intake of carbohydrates, particularly complex carbohydrates, and a reduction of
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symptoms; e.g., “improved depression, tension, anger, confusion, sadness, fatigue, 
alertness, and calmness...” (Johnson, 1998, p. 410). These findings may assist in 
explaining the impact of carbohydrates on menopausal symptoms.
Summary of Literature Review
In summary, this review has documented the increasing number of women who 
are approaching the menopausal transition, and the plethora of symptoms common 
among women of this age group that may affect their overall quality of life. The myriad 
of hormonal and metabolic changes that women in this phase of life experience may, 
indeed, place them at greater risk of insulin resistance (or metabolic syndrome), diabetes, 
and cardiovascular disease. Varying combinations of carbohydrates, fiber and fat have 
been explored to clarify their impact on a woman's state of health. It has been suggested 
that dietary changes may improve a woman’s symptoms; however, very little 
documentation bears that out, leaving unanswered questions.
Operational Definitions
The following operational definitions were used in this study.
Carbohydrates were measured using Block’s 98 Food Frequency Questionnaire®. 
Analysis of nutrients was conducted by Block Dietary E>ata Systems. Items used to 
represent carbohydrates were: percent of kilocalories from sweets and desserts; daily 
servings of vegetables; daily frequency of fruits and fruit juices; and daily servings of 
breads, cereals, rice and pasta.
Fiber was also measured using the Blue Block 98.2 Food Frequency 
Questionnaire® and the Block Dietary Data Systems’ nutrient analysis. Items used to
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represent fiber were dietary fiber from beans, dietary fiber from vegetables and fruit, 
dietary fiber from grains all listed in grams, and total dietary fiber listed in grams.
Menopausal symptoms were calculated using the Menopause Rating Scale. 
Symptoms were categorized according to the following dimensions: psychological 
symptoms, somato-vegetative symptoms, and urogenital symptoms.
A woman was considered perimenopausal if she fell between 42 and 65 years of 
age and had had a menstrual period within the past twelve months.
A woman was considered postmenopausal if she fell between 42 and 65 years of 
age and had not had a menstrual period within the past twelve months.
Theoretical Framework
The process being assessed in this study involves a woman’s menopausal 
transition; that is, the physiological adaptation of a woman’s body, usually from a 
lifelong pattern of menses, to cessation of menses. One must also consider the 
simultaneous impact of aging, recognizing the interconnectedness of the two. The 
conceptual framework used for this exploration was physiological adaptation. Hansen 
(1998) defined adaptation as the physiologic response of the body to “restore system 
homeostasis,” (p. 19) and is “essential to human function” (p. 19). Menopause is a part of 
the natural aging process in women, with symptoms that typically begin when the body 
has depleted its store of oocytes. Hansen (1998) wrote:
It is unknown whether the menopause, also known as climacteric, occurs because 
of depletion of ovarian follicles, with the resulting alteration of feedback to the 
hypothalamic-pituitary-adrenocortical (HPA) axis, or whether it occurs because of
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genetically programmed changes in neural input to the HPA axis, resulting in 
altered signaling to the ovaries. It is possible that both events serve a “pacemaker’ 
function.” (p. 901)
Even before the oocytes are exhausted in number, changes in the menstrual cycle 
are experienced, resulting in a decrease of fertility and irregular cycles. This irregularity 
may accompany the onset of symptoms and may begin at any point during 
perimenopause. It is unclear exactly what physiological mechanisms trigger symptoms. 
Hansen (1998) suggested that increased levels of follicle stimulating hormone, widely 
varying levels of estradiol, or “inappropriate inputs to the hypothalamus during altered 
HPA regulation” (p. 901) may explain the vasomotor instability so common in the 
menopausal transition. Collins (2005) stated that “these abrupt spikes of estradiol, 
progesterone, and testosterone, may occur during perimenopause and are often 
accompanied by both physical and psychological changes.”
Women experience a dynamic shift during the menopause transition and aging 
resulting in further physiological adaptation. The basal metabolism rate slows as a person 
begins to age. Since growth is no longer the priority as in childhood, adolescence, and 
young adulthood, the body needs fewer calories to sustain life. Aging initiates a chain of 
events which sets a negative feedback loop into motion.
An example of the negative feedback loop that serves as an adaptive mechanism 
in the body is as follows: Aging decreases the metabolism rate, less energy is needed to 
maintain the same amount of work, a reduction of energy is realized, the individual then 
reduces the caloric intake, no excess fat is stored, and optimal weight is maintained for 
that individual. If the individual does not reduce the caloric intake or increase the activity
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level, the middle aged woman may exhibit central or truncal obesity. Since estrogen is no 
longer being produced by the ovaries, the increased fat storage may be an attempt by the 
body to adapt to the decrease in estrogen by increasing the estrogen production in the 
adipose tissue. This could explain why women have a tendency to gain weight during the 
time of perimenopause.
Another example of the body’s adaptation to the changes specific to the 
menopausal transition is its adjustment to the varying levels of hormones. The production 
of estrogen decreases and shifts from the ovaries to other parts of the body during the 
menopausal transition, and is done primarily by the adrenal glands and the adipose tissue. 
The follicular stimulating hormone (FSH) and lutenizing hormone (LH) increases as the 
estrogen decreases (Speroff, Glass, & Kase, 1999). Physical changes, such as the onset of 
irregular menses result in fewer ovulatory cycles and decreased fertility, representing the 
body’s adaptation to the shifting production of hormones.
During the process of adapting to decreased levels of estrogen, the body ceases to 
menstruate (Speroff, Glass, & Kase, 1999). According to the accepted definition of 
menopause, this would be the end of the physical adaptation. How ever, since studies 
show that many women continue to experience menopausal symptoms years after the 
cessation of menses, (Barentsen, van de Weijer, van Gend, & Foekema, 2000), 
(Garamszegi, 1998), one would wronder if the body’s adaptation to menopause is, in fact, 
completed.
The body is a magnificent machine that can adjust to its environmental, 
psychological, social, and emotional stressors. It has systems within systems to fine tune 
processes, and has feedback loops to prevent damage from excesses or deficiencies. The
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framework of adaptation may be equated to the model of a coil. The coil represents the 
levels of adaptation within the body from the first symptom of menopause to the last 
symptom. The graphic representation of this physiological adaptation framework is 
portrayed in Figure 1. The base of the coil represents the phase prior to the menopausal 
transition, or premenopause. The coil represents the continuum of menopausal symptoms 
that are theoretically influenced by carbohydrate and fiber intake within the diet and the 
hormonal changes. The opposite end, or the top of the coil, indicates that a woman has 
successfully passed through the menopausal transition and has moved into a state of 
postmenopause.
Assumptions
The following assumptions were made during the study:
1. Women honestly and to the best of their recall completed the Food Frequency 
Questionnaire and the Menopause Rating Scale.




























METHODOLOGY OF THE STUDY
This study explored the relationship between dietary intake of carbohydrates and 
the severity of menopausal symptoms. The study design was descriptive in nature and 
used survey methods. The research questions explored were:
1. What is the relationship between dietary intake of carbohydrates and the 
severity of menopausal symptoms in perimenopausal and postmenopausal 
women?
2. What is the relationship between dietary intake of fiber and the severity of 
menopausal symptoms in perimenopausal and postmenopausal women?
This chapter will describe methods use for collection and analysis of data.
Population and Sample
The population of this study included adult women, 42 to 65 years of age, residing 
in a rural Upper Midwest area, who were able to read and comprehend English. Women 
were excluded from the study if they had had a tubal ligation within the past year or 
history of a hysterectomy; or were undergoing treatment for diabetes, cancer, or any 
condition requiring prescription steroid hormone or antipsychotic medication. A 
convenience sample was drawn from employees of a Midwestern university community 
consisting of about 16,000 individuals with approximately 1300 women being targeted 
for recruitment. Fifty-nine women were recruited through direct campus mailings,
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university wide e-mails, and personal contact. Two women who were not employees of 
the university heard about the study by word of mouth, and participated in the data 
collection.
Study Design and Instruments
The study design was descriptive and employed self-report measures to 
summarize biographic information, dietary intake, and frequency and severity of 
menopausal symptoms. These measures included three self-completed questionnaires: 
The Health History Form (HHF), The Menopause Rating Scale (MRS), and the Blue 
Block 98.2 Food Frequency Questionnaire® (FFQ); (see Appendix A for forms). 
Potential participants were contacted, and if interested, the woman called to schedule an 
appointment. During her appointment, the woman completed the HHF, the MRS, and the 
FFQ. Additional data were collected as part of a broader study, Integrative Analysis of 
Menopause (I AM); for example, each woman also completed the Menopause Type® 
Questionnaire, the Utian Quality of Life Scale, and a brief interview about the extent and 
type of physical activity. Body measurements were also taken. The instruments used in 
data collection are described below.
Health History Form
The Health History Form was adapted from an intake form developed by Collins 
(2000), and includes biographical information; medical and surgical history; menstrual 
and menopausal history; alternative treatments used for menopausal symptoms; and 
current medications and supplements. The FIHF was adapted from an intake form widely 
used in colleges of naturopathy, and has been used by Collins [a member of the I AM 
research team] with over “literally thousands of women (Collins, 2005)” in his clinical
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practice and in his consultation with physicians and other healthcare providers throughout 
the U. S. The form was further modified for the I AM study in collaboration with Dr. 
Collins; the modified HHF was pilot tested by this investigator, but no validity nor 
reliability studies have been conducted on the form. Ten women completed the HHF 
between June and August, 2004. Only one change (the addition of Last Menstrual Period) 
was made to the form. Detailed historical information collected using the HHF will be 
used in the broader I AM study; however, for the purposes of this study, the only data 
items used in the analysis were: participant’s marital status, her menopausal status 
(perimenopausal or postmenopausal), and the number of pregnancies that she reported. 
(Refer to Appendix A for form.)
Menopause Rating Scale
The Menopause Rating Scale (MRS), developed and tested by a group of German 
physicians (Heinemann, L, Potthoff, P, & Schneider, H., 2004), has been translated into 
nine languages and has been used throughout the world in assessing the severity of 
menopausal symptoms. (Refer to Appendix A for form.) This instrument collects 
information on eleven symptoms that may be divided into three subgroups -  
psychological, somato-vegatative, and urogenital. These dimensions explain 59 % of the 
total variance of menopausal symptoms in women (Heinemann, et al., 2003). The MRS 
developers used a 5-point response scale to score items, with zero representing “none,” 
and 4, “very severe” symptoms. Scores can range from 0 to 44. Data collected with the 
MRS has been shown to have total score reliability of 0.60 (Schneider, et al., 2000). The 
original study sampled 683 German women in early 1996, then re-sampled 306 of the 
same women late 1997 assessing their menopausal symptoms. The purpose of the re­
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sampling was to assess the reliability of the MRS instrument. Findings “indicated 
significant agreement of the total scores in the two MRS measurements classified by 
severity o f symptoms (p. 61).” Each subscale also had significant agreement between the 
samples as well. The reliability estimates for the somato-vegetative symptoms were 
(a = 0.25), for psychological symptoms were (a = 0.30), and for urological symptoms 
(a = 0.19).
Food Frequency Questionnaire (Block 98.2)
The third instrument, the Block 98.2 Food Frequency Questionnaire®, collected 
quantitative, descriptive information about usual eating habits, food consumption 
patterns, and nutrient intakes for the women within the last 12 months prior to the study. 
The Block FFQ, in use by over 700 research groups and public health agencies in the 
United States, was revised in 1998 based on the NHANES III food intake data. The 
questionnaire was updated to reflect changes in the American diet and includes foods 
representing at least 90 percent of the intakes of each of the nutrients on the NHANES III 
database, (Block et al., 1998). The Block FFQ contains a list of 150 food items, with 
participants responding to frequency of intake on a Likert Scale. Portion sizes are 
estimated using a visual guide (Block et al., 1998) (see Appendix A for form). 
Amanatidis et al. (2001) used the Block FFQ as a standard against which their 
Australian-developed FFQ (Commonwealth Scientific and Industrial Research 
Organization in 1993) was compared. Subar et al. (2001) compared reported dietary 
intakes using the Diet History Questionnaire (DHQ), Block Health Habits and History 
Questionnaire (1995 version of the Block FFQ), and the Willett FFQ to repeated 24-hour 
recalls. They found the Block FFQ and the DHQ to be “substantially better choices” for
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“assessing absolute intakes (p.1096).” The Block FFQ reported a mean correlation across 
all nutrients to be 0.54 for women.
Data Analysis
The completed FFQs were sent to Block Dietary Data Systems for analysis. The 
questionnaires were scanned, and results reported to the investigator. Items from these 
files were linked to other data items in the MRS and HHF to conduct the analysis. 
Analysis was completed in SPSS by Dr. Steve Owen, Professor, University of Texas 
Health Science Center at San Antonio. Data analysis was conducted using hierarchical 
(or sequential) regression, using two blocks to predict outcomes. The point of the block- 
wise approach was used to adjust the effects of dietary behaviors for a group of 
covariates. The first block included biographical data as covariates (marital status, 
menopausal status, number of pregnancies). The second block include the biographical 
data and also comprised the dietary variables, including total carbohydrates, total fiber, 
daily servings of vegetables, fruit and fruit juices, grains, and percent of kilocalories of 
from sweets and desserts. Block two in the second regression included the biographical 
data and also included the total fiber, fiber from beans, vegetables, fruits, and grains. The 
regression models used took into accounts all of the correlations of the variables 
simultaneously. These predictor variables will be discussed in relation to the MRS 
subscales (psychological, somato-vegetative, and urogenital).
Protection of Human Rights
Protocols for the study were reviewed and approved by the University of North 
Dakota Institutional Review Board. Informed consent was discussed with all participants 
prior to the onset of data collection, and women signed a detailed consent form,
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maintaining a separate copy for themselves (see Appendix B for form). Participation was 
voluntary, and subjects were advised that they could withdraw from the study at any time 
without repercussions.
Confidentiality was assured through several means. All data forms were marked 
with a university-assigned identification number, and data forms were kept in a locked 
file during data collection. Once the data files were linked, a master list of participants 
was created and given to the investigator for verification purposes. All identifying 
information found in the data files was then deleted prior to analysis, and a random 
identification number was assigned to each woman. Access to the computerized data files 
required a secure password, creating an additional level of security. The original data 
(according to university policy) will be maintained in a locked drawer for five years and 
then destroyed.
This chapter has reviewed the methods and procedures used in the collection and 




The purpose of this descriptive study was to explore the relationship between 
dietary intake of carbohydrates and fiber and menopausal symptoms. In this chapter, the 
sample demographics, the results of the Menopausal Rating Scale, and the dietary 
analysis will be presented. Findings related to the research questions will be presented. 
Data were analyzed using the Statistical Package for Social Sciences (SPSS). The level of 
significance for this study was set at less than 0.05.
Sample Demographics
Sixty-one women were invited to participate in this study. A total of sixty-one 
women completed the MRS, HHF, and FFQ questionnaires yielding a response rate of 
100.0 %. The ages of the women ranged from 42 to 64, with a mean of 51.6 years
(SD = 5.33). All of the women in the sample were Caucasian, and most of the 
women who participated in the study were married 75.4 % (n = 46), compared to 18% 
who were divorced (n_= 11), 1.6% who were widowed (n = 1), and 4.9% who were single 
(n=3).
Of the sixty-one women, 31% (n =19) were postmenopausal and 69% (n = 42) 
were considered perimenopausal. 78.7% (n = 48) were not using hormonal replacement 
therapy (HRT) and while 21.3 % (n = 13) of the women were using some form of 
hormone replacement therapy. The numbers of pregnancies for the sample were also
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noted. The mean number of pregnancies was 2.36 (SD =1.43), the median was 2, and the 
number of pregnancies in sample formed a bell curve. Demographic data were presented 
in Table 5.
























Table 6 measures the Cronbach coefficency of the Menopause Rating Scale tool
used in the sample. It described the ranges, means, and alpha reliabilities of the somato-
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vegetative, psychological, and urogenital dimensions according to The Menopause
Rating Scale. The desired alpha reliability for an assessment tool is 0.80. The alpha
coefficient for the somato-vegetative dimension was 0.84, the alpha coefficient for the
urological dimension was 0.75 percent, and the alpha coefficient for the psychological
test was 0.60. The scores range from 0 to 3.75 for the somato-vegetative score, from 0 to
3.25 for the psychological, and from 0 to 3.33 for the urological dimensions. (See Table
6). The mean scores for each dimension are also presented in Table 6. The means ranged
from 0.99 to 1.11, indicating that the symptoms were reported as mild.
Table 6. Description of Dimensions of Peri- & Postmenopausal Women According to the 
Menopause Rating Scale (n = 61).
Dimensions of MRS Range of scores Mean of scores (SD) a Reliability
Somato-vegetative 0-3.75 1.11 G6Z) 0.84
Psychological 0-3.25 1.07 (.81) 0.60
Urologenital 0-3.33 0.99 G85) 0.75
*Cronbach co-efficiency test
The Menopause Rating Scale data are presented in Table 7. The sample consisted 
of sixty-one women; however, cases were omitted for analysis if data was missing. 
Therefore, the symptoms for irritability and anxiety from only 60 women were used for 
analysis.
Frequencies
As indicated by the mean scores in Table 7, the majority of the women reported 
mild to moderate symptoms with a range of 35% (n = 21) for heart discomfort to 72.1 %
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(n = 44) for exhaustion. The exceptions to majority reporting mild to moderate symptoms 
was that the majority had no symptoms for heart discomfort at 63.4% (n = 39) and 
anxiety at 50.8% (n = 30). Conversely, 16.4% (n = 10) of the women in the sample 
reported that sleep problems were severe to very severe.











Hot Flashes 14 (23.0) 40 (65.5) 7 (11.5)
Heart Discomfort 39 (63.4) 21 (35.0) 1 (1.6)
Sleep Problems 14 (22.9) 37 (60.7) 10 (16.4)
Depressive Mood 19 (31.1) 37 (60.7) 5 (8.2)
Irritability 21 (35.0) 35 (58.3) 4 (6.7)
Anxiety 30 (50.8) 24 (39.3) 6 (9.9)
Exhaustion 10 (16.4) 44 (72.1) 7 (11.5)
Sexual Problems 22 (36.1) 33 (54.0) 6 (9.9)
Bladder Problems 27 (44.3) 31 (50.8) 3 (4.9)
Vaginal Dryness 24 (39.3) 31 (50.8) 6 (9.9)
Joint/Muscular
Pain
21 (35.0) 38 (61.9) 2 (3.1)
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with symptoms. The results were measured by a t-test which measured whether or not
two independent variables were related. In this test, nominal data were compared (e.g.
measuring the severity of the symptoms if the participant reported the symptom and the
menopausal status of the participant). If the p was less than 0.05, the variables were
related. If the p was greater than 0.05, the null hypothesis was rejected, and the variables
were independent of each other and not related. The variables showed no statistical
Table 8. Relationship of Menopausal Status of Peri- & Postmenopausal Women to 
Symptoms (n =61).
Table 8 compares the menopausal status (perimenopausal and postmenopausal)
Variable (Symptom) t-test Significance of t-test (2-tailed)
Hot Flashes -1.957 p=0.055
Heart Discomfort 0.435 p=0.665
Sleep Problems 0.008 p=0.993




Sexual Problems -0.739 p=0.463
Bladder Problems 0.697 p=0.489
Vaginal Dryness -1.676 p=0.099
Joint/Muscular Pain -0.211 p=0.834
* t-test
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significance between the type of symptoms and menopausal status meaning that there 
was no relationship between the menopausal status of the women and the menopausal 
symptoms the women were experiencing.
Table 9 presents data about the nutrients investigated in this study. Nutrients were 
categorized by carbohydrate (total grams of carbohydrates; number of daily servings of 
vegetables; fruits and fruit juices, and grains; and percent of kilocalorie from sweets and 
desserts) and fiber (total fiber in grams; total bean fiber in grams total fruit and vegetable 
fiber in grams; and total grain fiber in grams). Similar to the MRS responses, cases were 
omitted for a analysis if data was missing; therefore, the dietary intake data from only 54 
women was used for analysis.
Table 9. Frequency of Nutrient and Food Group Intake of Peri- & Postmenopausal 
Women (n = 54).
Independent Variable Mean of scores (SD) Range of scores
Carbohydrate
Grams of carbohydrate 184.22 00 i/1 4̂ 60.3-403.2
Daily servings vegetables 3.60 (2.16) 0.8-12.80
Daily servings fruits and juices 1.44 (1.02) 0.3-4.30
Daily servings grains 3.64 (2.42) 0.2-10.40
Percent of kcal sweets/desserts 12.30 (8.70) 1.2-45.0
Fiber
Grams of fiber 17.28 (9.19) 4.6-54.90
Grams of fiber-beans 2.72 (2.20) 0.04-11.74
Grams of fiber-vegetables & fruits 8.34 (4.84) 1.8-29.65
Grams fiber-grains 6.72 (5.21) 0.7-27.60
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A Pearson’s R correlational matrix was conducted for the perimenopausal (n =39) 
and postmenopausal women (n_=15) to look for a relationship between the multiple of 
variables including the three MRS subscales (somatic, psychological, and urological) and 
the carbohydrate and fiber variables. No unexpected correlationals were found. 
Relationships that were found were expected such as relationships between somatic and 
psychological variables as well as urological. Other expected relationships found were 
between fiber, fruit, and vegetables as well as relationship between carbohydrate and 
fiber. (See Table 10 for Pearson’s correlations of perimenopausal women and Table 11 
for postmenopausal women).
Research Questions
Research Question 1: What is the relationship between dietary intake of 
carbohydrates and the severity of menopausal symptoms in perimenopausal and 
postmenopausal women?
. Block 1 of the sequential regression model explained the variance associated with 
the demographic variables (number of pregnancies and menopausal status). Block 2 
explained the variance associated with dietary variables. This analysis was conducted for 
each dimension of the MRS (i.e. somatovegetative, psychological, and urogenital). (See 
Appendix C, Table 1 for Regression 1 presents results for carbohydrates). No significant 
relationships were noted for any of the three dimensions. Because the urogenital 
dimension seemed to explain a very small portion of variance, (R2 = .066 for Block 1) 
further analysis was conducted to explore the factors contributing to that variance. See 
Appendix C, Table 2 for squared semi-partial correlations for the variables. Over 9% of 
the variance in the urogenital dimension can be explained by the number of pregnancies.
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Table 10. Relationship Between Menopausal Symptoms, Carbohydrate and Fiber Intake, & Status of Perimenopausal Women.
Indep Somato Psycho Urogen #Pregn Serv Servin Serv % C H O  F ib  F ib  F ib  F ib  




# Preg 0.063 -0.165
Srv Veg 0.055 0.011
Srv Frt 0.008 -0.073
Srv Gm 0.144 0.195
% Swt 0.168 0.230
CHO 0.176 0.173
grams 


























0.616 0.656 -0.238 0.781
0.215 0.340 -0.088 0.432
0.717 0.233 -0.406 0.462




0.771 0.402 0.337 1.000
Table 11. Relationship Between Menopausal Symptoms, Carbohydrate and Fiber Intake, & Status of Postmenopausal Women.
Indep Serv Servin Serv % CHO Fib Fib Fib





Srv Veg 0.372 0.220
Srv Frt 0.218 0.207
Srv Gm -0.283 -0.108
% Swt -0.156 -0.140
CHO -0.221 -0.127
grams 
Fib gms -0.055 -0.114
Fib bean -0.137 -0.352
Fib 0.441 0.329
veg/fruit 























0.526 0.611 0.499 1.000




Research Question 2: What is the relationship between dietary intake of fiber and 
the severity of menopausal symptoms in perimenopausal and postmenopausal women? 
(See Table 10 for the Pearson's correlations of perimenopausal women and Table 11 for 
the postmenopausal women.) Table 3 in Appendix C showed the sequential regression 
analysis between the dependent variables (somatovegetative, psychological, and 
urogenital) and the independent variables (fiber intake). Similar to the results with 
carbohydrates, no significant relationship was noted with the fiber variables. Again, as in 
the previous discussion, the number of pregnancies further explains the variance of over 
9.4% for the urogenital dimension. (See Table 4 in Appendix C for squared partial and 




In this chapter, a brief summary of the study will be presented followed by a 
discussion and conclusions of study findings. A section of recommendations for research, 
practice, and education will also be included.
Summary
The purpose of this study was to explore the relationship between dietary intake 
of carbohydrates and fiber to menopausal symptoms. The design was a descriptive study 
that used self-reported surveys.
Methods of data collection involved completion of the Health History Form, the 
Block 98.1 Food Frequency Questionnaire, and the Menopause Rating Scale Instrument 
by sixty-one women from a Midwestern University city. The sample consisted of women 
ages 42 through 65 with a mean age of 51.6 years and with fairly homogeneous 
characteristics. All of the women were Caucasian, and most of the women who 
participated were married (74.5%, n = 46). In the total sample, the number of pregnancies 
the women had ranged zero to six with mean of 2.36 pregnancies. The women were 
divided into two categories with 68.9%, (n = 42) being considered perimenopausal and 
31.1% (n = 19) being postmenopausal.
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The findings related to the MRS instrument reliability for this study showed a 
strong measure of internal consistency of the menopausal symptoms. Therefore, a high 
reliability index for this MRS survey utilized for this study was revealed.
Menopausal symptoms were not associated with dietary intake of carbohydrate or 
fiber. The urological symptoms could have been caused from previous pregnancies.
Discussion and Conclusions
The sample was chosen by age because women between the ages of 40 and 65 
usually fall somewhere in the range of perimenopausal to postmenopausal. However, 
because no blood work was drawn to verify hormone levels of the perimenopausal 
women, there could have been women in the sample who had not reached the 
perimenopausal status and were not exhibiting menopausal symptoms at all. There was 
one woman in the sample with no menopausal symptoms. Many of the symptoms in the 
MRS could be construed as symptoms of aging, (e.g. sleep problems, joint, or muscular 
pain) or could be related to depression, anxiety, or mood disorders (e.g. depressive mood, 
irritability, anxiety, or sexual problems). These symptoms could have been from caused 
from hormonal changes or from other causes as well.
The MRS alpha reliability in the sample was much greater than when the tool was 
used in the study described in the literature review. The reliability estimates for original 
scores in literature review had scores for the somatovegetative symptoms as (a = 0.25), 
for psychological symptoms as (a = 0.30), and for urological symptoms as (a = 0.19).
The alpha coefficient for the somatovegetative dimension was 0.84, the alpha coefficient 
for the urological dimension was 0.75 percent, and the alpha coefficient for the 
psychological test was 0.60. Since desired alpha co-efficiency for a tool is 0.80, the
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somatovegetative dimension surpassed what was desired. The urological dimension was 
near what was expected, and though the psychological was much below the desired score 
of 0.80, which would normally be considered substandard, 0.60 for a psychological score 
is considered acceptable by scientists for this type of test.
The findings of the study did not show any significant statistical relationship 
between carbohydrate intake and menopausal symptoms. The mean total carbohydrate 
intake for the sample was 184.22 grams. This was above the 130 grams per day 
recommended by the USDA (2005) for women requiring a 2000 calorie per day intake, 
but not an excessively above average carbohydrate intake. Dietary Recommended Intake 
(USDA, 2005) for total carbohydrate intake for adults and children is a minimum of 130 
grams per day (a total of 45% to 65% of energy). Couston, Liu, and Reaven (1983), study 
linked the high carbohydrate diet of 60% with high triglycerides and low HDLs as 
compared to the 40% carbohydrate diet. Menopausal symptoms were not evaluated in 
this study, and the Coulston et al. (1983) study was only conducted for 10 days on a small 
sample showing limitations in sample size as well as length of study; however, it seems 
that this study was relative to the women in the sample in that these women also had a 
higher than recommended RDA carbohydrate intake.
It may noted that some of the women in the study anecdotally stated that they 
were eating a diet low in carbohydrates (e.g. Atkins type) and experiencing fewer 
menopausal symptoms. This was evident with the low range of 60 grams of 
carbohydrates in the sample. After analysis, however, the sample mean of 184.22 showed 
that the average woman was eating the recommended average amount of carbohydrates 
daily. Lupton (2002) also recommended an RDI of no more than 25 percent of the total
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caloric intake from sweets and food or drinks with added sugar. The sample mean intake 
for sweets and desserts was a percent of 12.30 which was less than half of what was 
recommended for an RDI for sweets, but due to the difficulty dividing the sweets from 
the fats in the dietary analysis from the percent sweet/ desserts calculation, the 
investigators were unable to assess the true sugar intake of the sample. The samples’ 
average daily intake for fruits was 1.44 servings. A USDA recommendation (Daily Food 
Guide) recommends 2-3 servings of fruits per day. The samples’ average daily intakes 
for vegetables were 3.60 servings. The USDA (Daily Food Guide) recommends 3-5 
servings of vegetables per day. Therefore, the sample met the minimum daily 
requirement for vegetables but did not meet the minimum daily requirement for fruits. It 
may also be noted that a public campaign to eat more fruits and vegetables was going on 
during the time when the dietary information was collected which may have had some 
influence on the amount of fruit and vegetables the sample were consuming daily.
The sample mean intake for grains was 3.64 servings per day. This was not 
specified as whole or refined grains in the analysis. USDA recommends a daily intake is 
at least 3 or more ounces of whole grains (specified) per day or 6-11 servings (Daily 
Food Guide) of grains per day. Therefore, our sample did not have an adequate sample of 
grain daily intake.
The recommended dietary fiber intake for women ages 31 to 70 is 21-25 grams 
per day. The daily intake of fiber for the sample was 17.28 grams which was very low in 
comparison to USDA recommendations (IOM, 2004). Initially, fiber intake did appear to 
explain small variation in urological symptoms when examined statistically, however 
with further analysis within the regression, the findings indicated that women with more
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pregnancies exhibited more frequent and/ or severe urogenital symptoms. When fiber was 
examined for practical significance, by looking at effect size instead of statistical 
significance, there was a squared semi-partial correlation of 0.049. The significance of 
the effect size showed that fiber independently contributed 5 percent of unique variance 
predicting over and beyond all of the rest of the predictors. According to Cohen’s (1988) 
guidelines, any variance labeled 0.02 is considered as a small predictor. A variance 
labeled 0.13 is considered a medium predictor, and a variance labeled 0.26 is considered 
a large predictor. Thus, number of pregnancies (.094), servings of grains (.054), grams of 
carbohydrates (.049), and fiber grains (.049) are all considered small to medium effect 
sizes and should be studied further in future studies.
Limitations
Limitations of this study included the small sample size. Due to the short amount 
of time allowed to solicit a sample, and the limited sample size of women employees at 
the university, the investigators were not able to obtain a larger sample size. Also, 
because of the number of variables included in the study (e.g. dietary intake of 
carbohydrate intake, fiber, and the eleven menopausal symptoms), the small sample size 
made the analysis difficult to interpret as to significant statistical correlations. This study 
was a small piece of the larger study I AM, and the sample was a result of the larger 
study. Had the investigator designed the study on an individual basis, a power analysis 
would have been completed and a larger sample would have been obtained. The power 
analysis concluded that a sample size of at least 435 to 578 women would have been 
needed to obtain the statistical significance from the data. Since the adequate sample size
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was not obtained, effect size which is independent of sample size was analyzed for 
practical significance.
Another limitation that existed was that there were no hormone levels drawn on 
the study participants. This information was necessary to determine that the women, 
though they fit the ages of perimenopause, were actually perimenopausal. The 
postmenopausal women had stated that they had ceased to menstruate and therefore, were 
clinically considered menopausal. If blood work had been drawn to evaluate the hormone 
levels of the perimenopausal women, there may have been evidence that some of the 
women were not in perimenopause at all, thus exhibiting little to no symptoms. Another 
limitation from the study was that the questionnaires were self-reported. It is assumed 
that the women answered they questions to the best of their abilities, but no scientific 
analysis was done to verify symptoms, dietary analysis, or hormonal levels at the time of 
data collection. As discussed in the review of literature, there appears to be an interaction 
between fiber, carbohydrates, and other physiological parameters, but the limitation of 
not being able to obtain blood work limited the study in establishing a link in a possible 
hormonal profile.
The food frequency questionnaire used was a valid and reliable tool to assess 
dietary intake, however, investigators found the analysis of the data difficult to interpret. 
Sweets and desserts were counted in with the carbohydrates in the analysis. This 
limitations of the output of the data made sorting the fat content of those foods from the 
carbohydrates difficult during the analysis. There was also no way to differentiate 
between monosaccharides, oligosaccharides, or polysaccharides in the analysis of the 
carbohydrates. Another limitation of the tool was that using a food frequency
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questionnaire, though is was the most widely used, reliable, and valid tool available, still 
depends on the participants memory and dietary recall. The information remains 
subjective and may be fallible.
A last limitation to consider was that though the MRS tool had been used 
frequently in many studies, there had not been many studies to prove the tool validity and 
reliability. This study did find the tool to have a good alpha reliability score on all three 
dimensions with the Cronbach’s co- efficiency alpha reliability test.
Recommendations
Implications for nursing research, practice, and education can be drawn from the 
findings of this study. To continue to investigate whether there is a relationship between 
carbohydrate intake and menopausal symptoms, the profession must conduct additional 
research in this area. Another recommendation would be to use a larger random sample to 
increase the generalizability of the findings. The sample group who participated in the 
study was probably too homogenous for optimal research. Obtaining blood work, perhaps 
estradiol, progesterone, and testosterone levels and a lipid panel could also prove to be 
beneficial when assessing symptoms and diet to determine if subjective data and 
objective data correlate well.
New areas for research could be considered based on findings of this study.
Future research that could be valuable and was recommended in the following areas: 
dietary interventions after a dietary analysis of carbohydrate intake and menopausal 
symptoms, adjusting different amounts of carbohydrate intakes and assessing menopausal 
symptoms, and adjusting different amounts of fiber intakes and assessing menopausal
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symptoms. Another area for research includes whether an increase of sweets and desserts 
have any impact on menopausal symptoms.
Recommendations for practice include continuing to promote dietary education of 
recommended daily dietary intakes for carbohydrates, fiber, and daily servings of fruits, 
vegetables, and grains. Any adjustments in diet may improve health if not improve 
menopausal symptoms.
Recommendations for nursing education and future research include using 
research findings to plan future studies in this area, as there are so few studies on dietary 
intake and menopausal symptoms. This study has not ruled out that correlations may exist 
that have not been explored. It is essential that this subject be explored more fully, since 






INTEGRATIVE ANALYSIS OF MENOPAUSE STUDY
Health History
❖  Please complete this patient intake and health history as thoroughly as possible.
❖  The form is used to learn about your unique healthcare needs.
❖  Print all information and mark anything you don't understand with a question 
mark.
❖  Fill out the Medications & Supplements page as complete as possible.
Name_____Date (MM/dd/yy)________
Date of Birth (MM/DD/YY)________ UND -NAID#___
Address__________
City_____  State  Zip Code 
Telephone (Home) ( 'l (Work) ( )
Cell Phone (__)______
E-Mail_______
Marital Status: Married___ Separated___ Divorced___ Widowed___ Single____
Live with: Spouse____ Children___ Parents____ Relatives____ Friends____
Alone
When and where did you last receive medical or health care?.
What was the reason?
MEDICAL HISTORY
What medical problems have you been treated for in you lifetime? (Please list)
HOSPITALIZATION AND SURGERY
Please list hospitalizations and surgeries you have had:
MOTOR VEHICLE OR OTHER ACCIDENTS
Please list type and date o f accident.
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R E P R O D U C T IV E  HISTORY/ G EN ERA L IN FO R M A TIO N
Write in the “Age” or “Number” as indicated. Write “Y”, for YES, if you have symptom now.
Write “P” if you ever had symptom in the PAST. Write an “N” if you NEVER had that symptom.
If a question does NOT APPLY, write “NA”. DO NOT LEAVE ANY SPACE BLANK
REPRODUCTION HISTORY
Age menses began
Date of Last Menstrua! Period
For the majority of your life:
Average number of days of bleeding 
Length of cycle (days between periods) 
Bleeding between periods?
Have cycles been regular?
If no, when did they become irregular? 
What is frequency of bleeding now? 
Painful menses? (Y. N or P)
Excessive flow? (Y, N or P)
Have you ever used Birth Control Pills
W h a t tvn<>9
Still Taking BCP?
If NO, date discontinued? (Mo/Yr) 
Are you sexually active?
Difficulty conceiving?
Number of pregnancies?




Used Hormone Replacement Therapy?
What is the Name of the HRT
Still Taking the HRT?
If NO, date discontinued (Mo/Yr)) 
Did you quit because of symptoms? 
What symptoms caused you to quit?
Did you quit because of fear of cancer? 
Other reason(s) you quit:
List symptoms that occurred when HRT stopped:
WELLNESS
Do you do breast self exam?
How often? (Example: monthly, quarterly) 
Breast exam by healthcare provider?
Last exam by provider? (MOo/Yr)
Last mammogram? (Mo/Yr)
Date of last Pap Smear? (Mo/Yr)
Have you EVER used tobacco?
If Yes, how many packs per day?
For how long? (Number of Years)
When discontinued? (Year you quit)
If you have experienced the following, how long?
Depression 
Mood swings 




Date symptoms began (Month/Year)
Complementary Therapies for Menopause
Place an “X” mark if you Currently, Never, or



















Please List All Of The Following and Bring Them With You To Your Appointment:
Prescription Medications “Over-The-Counter” Medications
Vitamins & Minerals Herbs
Soy or other Isoflavones All Other Supplements
Please provide Name o f Prescription or Supplement, the Dose, How Often you take it, 
How Long you have been taking it.
EXAMPLE
Name of Prescription or Supplement Dose How often How Long
Vitamin C 500mg 1 x day 1 year
Medications & Supplements
Name of Prescription or Supplement Dose How often How Long
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M edications & Supplements (continued)
Name of Prescription or Supplement Dose How often How Long




Menopause Rating Scale (MRS)
W hich of the following symptoms apply to you at this time? Please, mark the appropriate box for 
each symptom. For symptoms that do not apply, please mark 'none'.
Sym ptom s:
none mild moderate severe
| ------------ | ---------------1--------------1------




1. Hot flushes, sweating
(episodes of sweating).................................................................... . . . . □ □ □ □ □
2. Heart discomfort (unusual awareness of heart
beat, heart skipping, heart racing, tightness).......................... . . . . □ □ □ □ □
3. Sleep problems (difficulty in falling asleep,
difficulty in sleeping through, waking up early)....................... . . . . □ □ □ □ □
4 . Depressive mood (feeling down, sad, on the
verge of tears, lack of drive, mood swings)............................. . . . . □ □ □ □ □
5. Irritability (feeling nervous, inner tension,
feeling aggressive).......................................................................... . . . . □ □ □ □ □
6. Anxiety (inner restlessness, feeling panicky)........................... . . . . □ □ □ □ □
7. Physical and mental exhaustion (general decrease 
in performance, impaired memory, decrease in 
concentration, forgetfulness).............................................. ........... . . . □ □ □ □ □
8. Sexual problems (change in sexual desire, in
sexual activity and satisfaction).................................................... . . . □ □ □ □ □
9. Bladder problems (difficulty in urinating,
increased need to urinate, bladder incontinence)................... . . . □ □ □ □ □
10. Dryness of vagina (sensation of dryness or burning
in the vagina, difficulty with sexual intercourse)..................... . . . □ □ □ □ □
11. Joint and muscular discomfort (pain in the joints, 















O  Jan DAY YEAR
O  Feb
O  Mar CD CD 1998 0
O  Apr CD CD 1999 0
O  May CD CD 2000 0
O  Jun CD CD 2001 O
O  Jul CD 2002 0
O  Aug CD 2003 O
O  Sep CD 2004 0
O  Oct CD 2005 0
O  Nov CD 2006 0
O  Dec CD 2007 O
F o o d
Questionnaire
This form is about the foods you usually eat.
It will take about 30 - 40 minutes to complete.
•  Please answer each question as best you can. 
Estimate if you aren't sure.
• Use only a No. 2 pencil.
•  Fill in the circles completely, and erase 
completely if you make any changes.
Please print your name in this box. \ ___________
SEX
O  Male 
O  Female
If female, are you 
pregnant or 
breast feeding?
O  No 
O  Yes














CD CD CD 
CD CD CD 
CDGDCD 
CD CD CD 



















AVERAGE USE IN THE PAST YEAR
First, a few general questions LESSTHAN 1-2 3-4 5-6 1 1 1/2 2 3 4+
about what you eat. ONCE per per per per per per per per
per
WEEK
WEEK WEEK WEEK DAY DAY DAY DAY DAY
About how many servings of vegetables
do you eat, per day or per week, not 
counting salad or potatoes? o o O O o o o  - o o
About how many servings of fruit do you 
eat, not counting juices? o o O O o o o o o
How often do you eat cold cereal? o o O O o ° o O  ■ ;:; o A
How often do you use fat or oil in cooking? o o o o o o o o o
What kinds of fat or oil do
O  Don't know, or Pam 
O  Stick margarine 
O  Soft tub margarine 
O  Butter
ou usually use in cooking?
O  Butter/margarine blend 
O  Low-fat margarine 
O  Corn oil, vegetable oil 
O  Olive oil or canola oil
MARK ONLY ONE OR TWO
O  Lard, fatback, bacon fat 
O  Crisco
PLEASE DO NOT WRITE IN THIS AREA
i B o o i o o s a g o i i B a i o i o o o o o o 195475
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During the past year, have you taken any vitamins or minerals regularly, at least once a month?
O  No, not regularly O  Yes, fairly regularly
(IF YES) WHAT DID YOU TAKE FAIRLY REGULARLY?
VITAMIN TYPE HOW OFTEN FOR HOW MANY YEARS?
A FEW 1-3 4-6
DAYS DAYS DAYS LESS
DIDN'T per per per EVERY THAN 1 2 3-4 5-9 10+
TAKE MONTH WEEK WEEK DAY 1 YR. YEAR YEARS YEARS YEARS YEARS
Multiple Vitamins. Did you take...
Regular Once-A-Day, Centrum, or Thera type o o o o o o o o o o o
Stress-tabs or B-Complex type o o o o o o o o o o o
Antioxidant combination type o o o o o o o o o o o
Single Vitamins (not part of multiple vitamins)
Vitamin A (not beta-carotene) o o o o o o o o o o o
Beta-carotene o o o o o o o o o o o
Vitamin C o o o o o o o o o o o
Vitamin E o o o o o o o o o o o
Folic acid, folate o o o o. o o. o o o o o
Calcium, alone or combined with something else o o o o o o o o o o o
Zinc, alone or combined with something else o o o o o o o o o ; O o
Iron o o o o o o o o o O o
Selenium o o o o o o o o o O o
If you took Once-a-day, Centrum or Thera-type o  contain minerals, O  do not contain O  don't 
multiple vitamins, did you usually take types that iron, zinc, etc. minerals know
If you took vitamin C or vitamin E:
How many milligrams of vitamin C did you usually take, on the days you took it?
O  100 0  250 0  500 0  750 O  1000 0  1500 0  2000 0  3000+ O  Don’t know
How many lUs of vitamin E did you usually take, on the days you took it?
O  100 0  200 0  300 0  400 0  600 0  800 O  1000 0  2000+ O  Don’t know
Did you take any of these supplements at least once a month?
O  Ginkgo O  Ginseng O  St. John's Wort O  Kava Kava O  Echinacea O  Melatonin O  DHEA
O  Glucosamine/Chondroitin O  Something else O  Didn't take these
The next section is about your usual eating habits In the past year or so. This includes all meals or 
snacks, at home or in a restaurant or carry-out. There are two kinds of questions to answer for each food:
HOW OFTEN, on average, did you eat the food during the past year?
'Please DO NOT SKIP any foods. Mark "Never" if you didn’t eat it.
HOW MUCH did you usually eat of the food?
"Sometimes we ask how many you eat, such as 1 egg, 2 eggs, etc., ON THE DAYS YOU EAT IT. 
•Sometimes we ask "how much" as A, B, C or D. LOOK AT THE ENCLOSED PICTURES. For each 
food, pick the picture (bowls or plates) that looks the most like the serving size you usually eat.
(If you don't have pictures: A=1/4 cup, B=1/2 cup, C=1 cup, D=2 cups.)
•Sometimes we made the "D" column a darker color. This is just to remind you to make sure you 
really eat that large a serving.
EXAMPLE: This person drank apple juice twice a week, and had one glass each time. Once a week he ate a "C” sized 





























HOW MUCH EACH TIME 
SEE PORTION SIZE 
PICTURES FOR A-B-C-D
Apple juice o o o o o • o o o How many glasses each time 1 o2 o3 O4























HOW MUCH EACH TIME
HOW  OFTEN NEVER How many glasses on the
YEAR MONTH MONTH WEEK WEEK WEEK WEEK days you drink it?




Tomato juice or V-8 juice O o o o o o o o o O1 o2 O3 o




juice, including fresh, frozen or bottled O o o o o o o o o each time O1 o2 o3 9
When you drink orange juice, how often do o Usually calcium-fortified cD 1 don't know
you drink a calcium-fortified brand? o Sometimes calcium-fortified O  I don't drink orange juice
o Hardly ever calcium-fortified
Other real fruit juices like apple 









How manyKool-Aid, Hi-C, or other . y
drinks with added vitamin C O o O o o o o o O glasses o o2 o3 9 .
Drinks with some juice in them, 







y . - -
?
Instant breakfast milkshakes like How many
Carnation, diet shakes like SlimFast, O o O o o o o o O glasses or o o o o
or liquid supplements like Ensure cans 1 2 3
Glasses of milk (any kind) O o O o o o o o O
How many 
glasses o. 1 ' • o2 O3 o-:;4 ;
When you drink glasses of milk, what kind do you usually drink? MARK ONLY ONE:
O  Whole milk O  Reduced-fat 2% milk O  Low-fat 1 % milk O  Non-fat milk
O  Rice milk ■ O  Soy milk O  I don't drink milk or soy milk
HOW OFTEN NEVER FEW / YEAR ONCE/MONTH 2-3 TIMES/ MONTH ONCE/WEEK TWICE/W E E K 3-4 TIMES/ WEEK 5 -1  TIM ES / W EEK EVERY | DAY 1 HOW MUCH EACH TIME




o o o o
drinks like Snapple (nel diet drinks) 1 2 3-4 5+
How many
Beer or non-alcoholic beer o o o o o o o o o bottles or o o o o
cans 1 2 3-4 V v
What kind? MARK ONLY ONE: O  Regular beer O  Light beer O  Non-alcoholic beer O  1 don't drink beer
Wine or wine coolers o o O o o O o o o
How many 
glasses o1. o2 O3-4 o ;5+







Glasses of water, tap or bottled o o O o o O o o o
How many 
glasses. o.... r <•, o2 O -3*4 o5+
















What do you usually add to coffee?
MARK ONLY ONE: c Cream or half & half O  Nondairy creamer O  Milk O  None of these
O  Nondairy creamer O  Milk O  None of these
Do you usually add sugar (or honey) to coffee? c No O  Yes IF YES, how many teaspoons each cup? C D © © ©
Do you usually add sugar (or honey) to tea? O  No O  Yes IF YES, how many teaspoons each cup? CD CD <S) dD
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195475
PLEASE DO MOT WRITE IN THIS AREA
noooooaoaaaaioiiiooBooffllil
A FEW 2-3 2 3-4 5-6 HOW MUCH EACH TIME






WEEK WEEK WEEK DAY PICTURES FOR A-B-C-D
How often do you eat each of the following fruits, just during the 2-3 months when they are in season?
Raw peaches, apricots, nectarines, 
while they are in season o o o o o o o o o
How many 
each time o1/2 01 o2 oV i.3 ..
Cantaloupe, in season o o o o o o o o o How much o1/® o1/4 o1/2 o.
















Any other fruit in season, like o o o o o o o o o How much o o o ograpes, honeydew, pineapple, kiwi A B c D
How often do you eat the following foods alL j?  Estimate your average for the whole year.
Bananas o o o o O o o o o How many each time o1/2 01 O2 ' o
Apples or pears o o o o O o o o o How many each time o1/2 01 o2 ' • a i
Oranges or tangerines o o o o o o o o o How many each time O 01 o2 o





Canned fruit like applesauce, fruit o o o o o o o o o How much o o O ococktail, or dried fruit like raisins A B c D
HOW OFTEN NEVER ~ m rYEAR ONC i i  MONTH
2-3 Times/- 
MONTH U ncS TWEEK
TV/ltoWEEK





OAY HOW MlJCH EACH TIM
Eggs, including egg biscuits or Egg 
McMuffins (Not egg substitutes) o o o O o o o o o
How many 
eggs each time 01 o2 p3









Breakfast sausage, including o o o o o o o o o How many pieces o o o osausage biscuits 1 2 3 4
Pancakes, waffles, French toast, 
Pop Tarts o o o o o o o o o
How many 
pieces o o2 O. ■' 3- , o• ' 4  . •
Breakfast bars, granola bars, o o o o o o o o o How many o o o oPower bars 1 2 3
Cooked cereals like oatmeal, o o o o o o O ' o o Which bowl o o o
cream of wheat or grits B C
High-fiber cereals like All Bran, o o o o o o o o o Which bowl o o oRaisin Bran, Fruit-n-Fiber B C D
Which high-fiber cereal do you eat most often? MARK ONLY ONE: O  All Bran or Bran Buds O  Raisin Bran
O  Fiber One, Fruit-n-Fiber, etc. O  Something else O  1 don't know 0  ,1 don't eat it
Product 19, Just Right or o o o o o O o o o Which bowl o o oTotal cereal B C
Any other cold cereal, like Com o o o o o O o o o Which bowl o o o
Flakes, Cheerios, Special K B  . C D
Milk or milk substitutes on cereal o o o o o O o o o How many oz. on cereal o3 o z. o4-5 oz. O6-7 oz. o8+ o z.
Yogurt or frozen yogurt o o o o o O o o o How much oA oB OC o0
Cheese, sliced cheese or cheese o o o o o O o o o How many slices o o o ospread, including on sandwiches 1 2 3
When you eat cheese, is it O  Usually low-fat O  Sometimes low-fat O  Hardly ever low-fat O  Don't <now/don't eat
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HOW MUCH EACH TIME 
SEE PORTION SIZE  
PICTURES FOR A-B-C-D
How often do you eat the following vegetables, including fresh, frozen, canned or in stir-fry, at home or 
in a restaurant?
Broccoli o o o o o o o o o Howmuch oA oB oc oD
Carrots, or mixed vegetables or 
stews containing carrots
o o o o o o o o o Howmuch oA oB Oc o0
Corn o o o o o o o o o Howmuch oA oB Oc oD
Green beans or green peas o o o o o o o o o Howmuch oA oB Oc oD
Spinach o o o o o o o o o Howmuch oA o Oc o0
Mustard greens, turnip greens, collards o o o o o o o o o Howmuch oA oB  . Oc oD
French fries, fried potatoes or hash browns o o o o o o o o o Howmuch oA oB Oc oD
White potatoes not fried, incl. boiled, 
baked, mashed & potato salad
o o o o o o o o o Howmuch oA oB Oc oD
Sweet potatoes, yams (Not in pie) o o o o o o o o o Howmuch oA OB Oc O0
Cole slaw, cabbage o o o o o o o o o Howmuch OA o-B Oc OD
Green salad o o o o o o o o o Howmuch oA oB Oc OD
Raw tomatoes, including in salad o o o o o o o o o Howmuch O o O-Vj. 1 ; • O












Is your salad dressing O  Usually low-fat O  Sometimes low-fat O  Hardly ever low-fat O  Don't know/don't use






PAT... HOW MUCH EACH TIME
Any other vegetable, like okra, 
squash, cooked green peppers
o o o o o o o o o Howmuch oA oB Oc o□
Refried beans or bean burritos o o o o o o o o o Howmuch oA oB O  c . o□
Chili with beans (with or without meat) o o o o o o o o o Howmuch oA OB Oc o0
Baked beans, black-eye peas, 
pintos, any other dried beans o o o o o o o o o
How
much oA oB • Oc OD
Vegetable stew o o o o o o o o o WhichBowl oB Oc o0
Vegetable soup, vegetable beef, 
chicken vegetable, or tomato soup o o o o o o o o o
Which
Bowl oB Oc OD
Split pea, bean or lentil soup o o o o o o o o o WhichBowl oB Oc OD
Any other soup, like chicken noodle, 
chowder, mushroom, instant soups o o o o o o o o o
Which
Bowl oB Oc O0
Spaghetti, lasagna or other pasta 
with tomato sauce o o o o o o o o o How o o o o
Cheese dishes without tomato 
sauce, like macaroni and cheese
o o o o o o o o o Howmuch oA oB Oc oD








































HOW MUCH EACH TIME
SEE PORTION SIZE 
PICTURES FOR A-B-C-D
Do y o u  ever eat chicken, meat or fish? O  Yes O  No IF NO, SKIP TO NEXT PAGE
Hamburgers, cheeseburgers, meat 
loaf, at home or in a restaurant
o o O o O o o o o How much meat o1/8 lb. o1/4 lb. o1/2 lb. o3/4 lb.
Tacos, burritos, enchiladas, 










Beef steaks, roasts, pot roast, or in 
frozen dinners or sandwiches
o o o o o o o o o Howmuch OA oB oc OD
How do you like beef cooked? o  Rare O  Medium O  Well done O  1 donl eat beef
Pork chops, pork roasts, 
or dinner ham o O o o O o o o °
How
much OA oB Oc o0
When you eat meat, do you o  Avoid eating the fat O  Sometimes eat the fat O  Often eat the fa cD I don't eat meat
Veal, lamb or deer meat o O o o O o o O O Howmuch oA oB oc oD
Ribs, spareribs o O o o O o o O O How many ribs o3-4 o5-8 o7-8 o9+
Liver, including chicken livers or 









Gizzard, pork neckbones, chitlins, 
pigs feet, etc. o O o o O o o O o Howmuch oA oB Oc oD
Mixed dishes with beef or pork, like 
stew, corned beef hash, stuffed 
cabbage, meat dish with noodles
o O o o O o o O o Howmuch oA oB Oc oD
Mixed dishes with chicken, like /V i; 
chicken casserole, chicken & 
noodles, pot pie or in stir-fry
o
V.-
O o o o o o O o .?■ Howmuch










Fried chicken, at home or in a 
restaurant O O o o O o o o o








Chicken or turkey not fried, such as 
baked, grilled, or on sandwiches o o; o o O o o o i Howmuch oA o■ J B  . o'.. c  ,< O,D
When you eat chicken, do you O  Avoid eating the skin O  Sometimes eat the skin O  Often eat the skin
HOW OFTEN NEVER FEW/ ONCE/MONTH 2-3 TIMES/ MONTH ONCE/WEEK TWICE/WEEK 3-4 TIMES/ WEEK 5-6 TIMES/ WEEK
EVERY
DAY HOW MUCH EACH TIME
Oysters o o o o o o o o o Howmuch oA oB Oc oD
Other shellfish like shrimp, 
scallops, crabs
o O o o o o o o o Howmuch o<" :  A-V Oa O■ ; C  " oD
Tuna, tuna salad, tuna casserole o o o o o o o o o How much of the tuna oA OB oc O0
Fried fish or fish sandwich, at home 
or in a restaurant
o o o o o o : O o o Howmuch ", A o- 8  : Oc
b
D










Hot dogs, or sausage like Polish, 









• 4  ■;
Are your hot dogs o  Usually low-fat O  Sometimes low-fat O  Hardly ever low-fat O  Don't know/don't eat them
Boloney, sliced ham, turkey 
lunch meat, other lunch meat o O o o o o o o o
How 
many ' 
slices o", t . . o2 o3 o' 4-,"/












TIMES EVERY HOW MUCH EACH TIME
per per per per per per per DAY SEE PORTION SIZE
YEAR MONTH MONTH WEEK WEEK WEEK WEEK PICTU RES F O R A - B-C-D
Noodles, macaroni, pasta salad o o o o o o O o o Howmuch OA OB oc OD
Tofu, bean curd o o o o o o O o o
How
much oA oB Oc OD
Meat substitutes, such as o o o o o o o o o How many patties o o o oveggie burgers, Gardenburgers 1 2 3 4
Chinese food, Thai or other Asian o o o o o o o o o How o o o o
food, not counted above much A B C D
Snacks like potato chips, corn o Howchips, popcorn (not pretzels) o o o o o o o o much oA oB Oc OD
Are these snacks O  Usually low-fat O  Sometimes low-fat O  Hardly ever low-fat O  Don't know/don't eat






DAY HOW MUCH EACH TIME
Peanuts, other nuts or seeds o o o o o o o o o Howmuch oA OB Oc O0
Crackers o o o o o o o o o
How
much oA oB Oc OD






Cake, sweet rolls, coffee cake o o o o o o o o o Howmuch oA oB oc OD
Are they O  Usually low-fat O  Sometimes low-fat O  Hardly ever low-fat O  Don't know/don't eat
Cookies o o o o 9 o o o °
How
many o1-2 o3-5 O8-7 O8+
Are your cookies O  Usually low-fat O  Sometimes low-fat O  Hardly ever low-fat O  I don't know/don't eat
Ice cream, ice milk, ice cream bars o o o o o o o o °
How
. much • ° ? !
Is your ice cream O  Usually low-fat O  Sometimes low-fat O  Hardly ever low-fat O  I don't know/don't eat
Pumpkin pie, sweet potato pie o o o o o o o o o How many slices o1/2 01 o 2 ' o• •3 •
Any other pie or cobbler o o o o o o o o o How many slices o1/2 01 O2 o3
Chocolate candy, candy bars o o o o o o o o o How many bars CDsmall CDmedium CDlarge -CDlarge
Other candy, not chocolate, like 
hard candy, caramel, jelly beans o o o o o o o o o
How many 
pieces o1-2 o3 -5 o5-7 o8+
PLEASE DO NOT WRITE IN THIS AREA
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NEVER 2*3 2 3-4 5*6
E V E R ')
2+ HOW MUCH EACH TIME
HOW OFTEN O R A FEW ONCE T IM ES ONCE T IM ES T IM ES T IM ES T IM E ST IM E S
PER
YEAR
per per per per per per D A Y per S E E  P O R T I O N  S I Z E
MONTh MONTH W EEK W EEK W EEK W EEK DAY P I C T U R E S  F O R  A - B - C - D
Biscuits or muffins o o o o o O o o o How many 
e a c h  t im e
O o o o
Rolls, hamburger buns, English 
muffins, bagels o o o o o O o o o How many e a c h  t im e o1/2 01 o2 o3
Dark bread like rye or whole 












White bread or toast, including o o o o o o o o o How many o o o o
French, Italian, or in sandwiches slices each 1 2 3 4
Corn bread, corn muffins o o o o o o o o o How many o o o opieces 1 2 3 4






Rice, or dishes made with rice o o o o o o o o o How much o o o o
A B C □
Margarine (not butter) on bread or 
on potatoes or vegetables, etc. o o o o o o o o °l
How many 







Butter (not margarine) on bread or 














Peanut butter o o o o o o o o o Howmany Tbsp 0 1 o2 o3 O4
Jelly, jam, or syrup o o o o 6 o o o o Howmany Tbsp 01 o2 o'3 ;; o. -'4 ' .
Mayonnaise, sandwich spreads o o o o o o o o o Howmany Tbsp 01 o2 o3 o4
Catsup, salsa or chile peppers ''t '-O '" o o o o o o» o O ' ■ How .; many Tbsp 01 o2 O  :3 o4
Mustard, soy sauce, steak sauce, 









Did you use the pictures to choose your serving size on this form? O  Yes O  No O  I didn't have any pictures. 
Would you say your health is O  Excellent O  Very good O  Good O  Fair O  Poor
How many times have you gone on a diet? O  Never 0  1-2 O  3-5 O  6-8 O  9 or more
Did you ever drink more beer, wine or liquor than you do now? O  Yes O  No
How many hours do you watch television or video, per day or per week on average?
O  None O  1-6 hours/week O  1 hour/day O  2 hours/day O  3 hours/day O  4 + hours/day
Do you smoke cigarettes now? o No O  Yes
IF YES, On the average about how many cigarettes a day do you smoke now?
0  1-5 0  6-14 0  15-24 0  25-34 0  35 or more
What language do you usually speak at home or with friends?
O  English O  Spanish O  Something else O  English & something else equally
What Is your ethnic group? (MARK ONE OR MORE)
O  Hispanic or Latino O  Black or African American
O  White, not Hispanic O  Asian
O  American Indian or Alaska Native 
O  Native Hawaiian or Other Pacific Islander
SB IBSTEB B S ! I 1





INTEGRATIVE ANALYSIS OF MENOPAUSE STUDY
Consent Form
This study is being conducted by Dr. Donna Morris, faculty at the UND College of 
Nursing (CON); Kathy Edwards, RN, BSN, master’s student in the CON; Debbie 
Evenson, doctoral student in the CON; Dr. Glenda Lindseth, faculty at the CON; Dr. 
Steve Owen, biostatistician and faculty at the University of Texas Health Science Center 
at San Antonio; and Dr. Joseph Collins, ND, author of Discover your menopause type 
and the Menopause Type® Questionnaire.
The purposes of this study is to evaluate the nutritional intake, symptoms that affect 
quality of life, and physical activity patterns that women experience as they approach, go 
through and complete menopause; and to assess the impact of foot reflexology on 
women. You were identified as a possible participant because your age fell between 42 
and 65 years. If you decide to participate in this study, you will be asked to complete 
several forms and procedures, including the following:
• Health and physical activity information, several menopause questionnaires, and a 
questionnaire detailing your nutritional intake. In addition, some body 
measurements (for example, height weight, waist) will be taken.
• Blood tests that will provide information about your hormone levels and the 
amount of sugar in your blood.
• The menopause questionnaires a few weeks after your appointment (by mail)
Over the next 6 months a random sample of women will be invited to participate in foot 
reflexology treatments. All women participating in the study will be invited to complete 
the menopause questionnaires and a daily log of symptoms for a two-week period.
Once all of the treatments have been completed, you will have an opportunity to review 
the results of the Food Frequency Questionnaire and the lab test results. Upon your 
approval, the laboratory test results will be sent to your primary physician.
Participation in the initial visit will take approximately 1 Vi — 2 hours. Completion of the 
follow-up questionnaires will take approximately 15-30 minutes. Each reflexology 
treatment will last for approximately one hour. Completion of the menopause 
questionnaires and the daily log should take a maximum of 15 minutes per day for two 
weeks. Altogether, women participating in this study will spend about 3 to 5 Vi hours 
over a period of 6 months, the variation depending on how many reflexology treatments 
you receive.
Answering questions related to your health may cause you to feel sad or upset. If this 
should occur, one of the investigators will be happy to talk further with you, and to refer 
you to the UND Employee Assistance Program if you so desire.
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Your participation in this study will help healthcare providers to better understand and 
work with women going through menopause, and will ultimately assist women in making 
more effective choices for themselves. It will also help us to document the effects of 
reflexology treatments. In brief, you will play an important role in the ongoing 
development of optimal women’s health care, affecting women today and in future 
generations.
All information that you share with the research team is confidential. The data collected 
during this study will be kept either in a locked file drawer (paper copies) in the principal 
investigator’s office, or in automated files with security protection. The data will be kept 
for a minimum of three years and then destroyed. Only the research team and people who 
audit IRB procedures will have access to the data. If the results of this study are written in 
a scientific journal or presented at a scientific meeting, neither your name nor any 
identifying information will be used. Any information that is obtained in connection with 
this study and that can be identified with you will remain confidential and will be 
disclosed only with your permission.
Your decision to take part in this research study is entirely voluntary. If you decide to 
participate, you are free to discontinue participation at any time without it being held 
against you.
The investigators involved are available to answer any questions you have concerning 
this program. In addition, you are encouraged to ask any questions concerning this 
program that you may have in the future. Questions may be asked by calling:
Dr. Donna Morris at (701) 777-4529, Ms. Kathy Edwards at (701) 240-4674, or Ms. 
Debbie Evenson at (701) 777-6045. If you have any other questions or concerns, please 
call the Office of Research and Program Development at (701) 777-4279.
You understand that all information (including results of the questionnaires and surveys, 
and laboratory results) is being collected for research purposes only and is not a substitute 
for medical care.
All of your questions have been answered and you have been encouraged to ask any 
questions that you may have concerning this study in the future.
You have read all of the above and willingly agree to participate in this study explained 




INTEGRATIVE ANALYSIS OF MENOPAUSE STUDY 
Consent for Laboratory Test Results Release
I hereby authorize you to forward abnormal laboratory results to my primary physician 
upon receipt.
YES NO
Upon completion of this study, I hereby authorize you to forward all laboratory results to 
my primary physician.
YES NO
If yes to either of the above: 
Physician’s Name_______
Address.
City. State Zip Code.






Table 12. Summaries of Regression Models Predicting Dimensions of Carbohydrate 
Intake and Menopausal Symptoms (n = 54).
Dependent 
Variable (MRS 











-.116 F  5,48 = 0.28,/? = .92
Psychological Block 1 .017 F  2,58 = 1.53,/? =.23
Psychological Block 2 -.009 F 5A8 =0.49,/? = 78
Urogenital Block 1 .066 F 2,58 =3.10,/? = .05
Urogenital Block 2 .030 F  5,48= 1.32,/? = .27
Note. For Psychological and Urogenital dimensions, Block 1 and Block 2 predictor 
variables are not restated. * p < .05 for statistical significance. ** Hierarchical Regression 
Model
63
Table 13. Proportion of Unique Variance Explained by Carbohydrate Predictors Using






Menopausal Status .093 .009 trivial
Number Pregnancies .307 .094 small
Grams Carbohydrates .221 .049 small
Servings Vegetables .141 .020 small
Servings Fruits .015 <001 trivial
Servings Grains .232 .054 small
Percent .057 .003 trivial
sweets/desserts
* effect sizes: small >0.02, medium >0.13, large > 0.26
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Table 14. Summaries of Regression Models Predicting Dimensions of Fiber Intake and 
Menopausal Symptoms (n = 54).
Dependent 
Variable (MRS 
Dimension) Predictor Variables Adjusted R2









Fiber: Vegetables & 
Fruits
Fiber: Grains
.015 F  4.49 ~ 1.20,/?= .32
Psychological Block 1 .017 F 2.58 ~ 153,p  =.23
Psychological Block 2 .016 F  4 — 1.22,/? = .31
Urogenital Block 1 .066 F 2.58 = 3.10, p  = 
.05
Urogenital Block 2 .060 -k 'O II t—» bo OO II 4̂
Note. For Psychological and Urogenital dimensions, Block 1 and Block 2 predictor 
variables are not restated. * p < .05 for statistical significance. ** Hierarchical Regression 
Model
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Table 15. Proportion of Unique Variance Explained by Fiber Predictors Using the






Menopausal Status .093 .009 trivial
Number Pregnancies .307 .094 small
Grams Fiber .075 .006 trivial
Fiber: Beans .057 .003 trivial
Fiber: Vegetables, and 
Fruits
.098 .010 trivial
Fiber: Grains .221 .049 small




For the purpose of this study, the following definitions were used:
Carbohydrate may be described in a number of different manners, but the universal 
method of distinguishing a carbohydrate from another food group is to classify it by its 
chemical formula C:H:0 of 1:2:1. Carbohydrates may be grouped into sugars, 
oligosaccharides, and polysaccharides, (Mann, 2001).
Sugars include three main subgroups: monosaccharides (glucose, fructose, and 
galactose), disaccharides (sucrose, lactose, and maltose), and alcohol sugars (sorbitol and 
mannitol). According to Mann (2001), “The 3 monosaccarides (glucose, fructose, and 
galactose) are the building blocks of naturally occurring di-, oligo-, and polysaccharides,
(P 59).”
Glucose and fructose are naturally combined to formed sucrose, which is found 
in honey, sugar cane and beets, some vegetables, fruits, and berries. Lactose is naturally 
formed from glucose, and galactose and is found in milk and some milk products. The 
disaccharide, maltose, is two glucose molecules naturally combined and is found in 
barley and wheat sprouts. The sugar alcohol, sorbital, also occurs naturally in some fruit, 
(Mann, 2001).
Oligosaccharides consist of maltodextrins, raffinose, stachyose, verbascose, and 
fructooligosaccharides. These carbohydrates may be found naturally in plant seeds, 
grains, vegetables, and other plants, or they may be produced industrially. 
Oligosaccharides, with the exception of maltodextrins, are not digested in the small
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intestine. Maltodextrins are used as sweeteners and fat substitutes to modify food textures 
to increase carbohydydrate content and decrease fat content in foods, (Mann, 2001). 
Polysaccharides consist of starch, modified starch, or non starch polysaccharides. The 
starch carbohydrates naturally occur as partial crystalline granules classified as either 
amylase or amylopectin Amylopectin is found in maize, rice, barley, and sorghum.
Cereal starches contain up to one third of amylase in content. When in the crystalline 
form, both amylopectin and amylase are indigestible to humans and insoluble in water. 
When heated, however, the crystalline form breaks down into a gelatin form which may 
be digested, and this form is called modified starch. The third form of polysaccharide is 
non-starch which consists of insoluble material including cellulose or hemicellulose and 
soluble material including pectins, beta-glucans, mucilates, and gums. These materials 
are components of dietary fiber, (Mann, 2001).
Dietary fiber may be defined as “substances that cannot be broken down by human 
digestive enzymes,” (Sizer & Whitney, 2004, p97). Fiber may be slightly broken down 
by bacteria that reside in the human digestive tract. Fiber may be classified as either 
soluble or insoluble. “Soluble fibers dissolve in water and have a gummy or gel-like 
appearance (e g., fruit pectin)”, (Sizer & Whitney, 2004, p. 97). Insoluble fibers do not 
dissolve in water and “comprise the tough, fibrous structures of fruit, vegetables, and 
grains”, (Sizer & Whitney, 2004, p. 97). Thus, most fiber acts as roughage, aiding in 
digestion and elimination.
Climacteric refers to the time that marks the cessation of a woman’s reproductive period, 
(Speroff, Glass, & Kase, 1999).
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Menopause symptoms refers to any symptoms, whether objective or subjective, that a 
woman may experience during the time her body takes to adjust to declining estrogen, 
progesterone, or androgen levels, (SperofF, Glass, & Kase, 1999).
Psychological symptoms include depressed feelings, irritability, anxiety, and feelings of 
exhaustion.
Somatovegetative symptoms include sweating or hot flashes, cardiac complaints, 
sleeping disorders, joint and muscular complaints.
Urogenital symptoms include sexual problems, urinary complaints, and vaginal dryness, 
Postmenopausal status refers to the characterization of a woman who has experienced 
cessation of menses for a period of one year (SperofF, Glass, & Kase, 1999). 
Perimenopausal status refers to the characterization of years prior to menopause that 
include the changes from a regular ovulatory cycle to the cessation of menses. It may be 
used interchangeably with menopause transition, and is not necessarily characterized by 
an irregular menses, (North American Menopause Society, 2004).
Metabolic syndrome refers to any person at increased risk for coronary heart disease as 
a result of having three or more of the following risk factors: obesity, dyslipidemia, 
hypertension, insulin resistance, sedentary lifestyle, or postmenopausal status.
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